RogerRodbyMD

PubMed

• 1 citations
  Pathophysiology of Hepatorenal Syndrome.
  Juan Carlos Q Velez, Nyan Latt, Roger A Rodby
  Advances in Kidney Disease and Health. 2024-03-01
• Hypertension with Hypokalemic Metabolic Alkalosis: The Diagnosis Is Apparent.
  Roger Rodby
  Clinical Journal of the American Society of Nephrology. 2023-07-01
• 7 citations
  COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry.
  Meryl Waldman, Ninet Sinaii, Edgar V Lerma, Anila Abraham Kurien, Kenar D Jhaveri
  Kidney360. 2023-03-01

Journal Articles

• Gesundheitsökonomische aspekte der anwendung von irbesartan bei patienten mit typ-2-diabetes, nephropathie und hypertonie in Deutschland (Health economic consequences ...  
  Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Ritz E, Dtsch Med Wochenschr
• Protecting those fabulous filters.  
  Rodby RA, Diabetes Forecast
• Economic implications of ACE inhibition for diabetic nephropathy.  
  Rodby RA, ACE Inhibition
• Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy.  
  Schwartz ME, Lewis EJ, Leonard-Martin T, Breyer Lewis J, Battle D, Nephrol Dial and Transplant
• Spectrum of disease in familial focal and segmental glomerulosclerosis.  
  Conlon PJ, Lynn K, Winn M, Quarles LD, Membe ML, Pericak-Vance M, Speer M, Howell DN, Kidney Int
• Effect of intensive blood pressure control on the course of type I diabetic nephropathy.  
  Lewis J, Berl T, Bain R, Rohde R, Lewis E, Am J Kid Dis
• Captopril induced reduction of serum levels of transforming growth factor-ß1 correlates with long-term renoprotection in insulin dependent diabetic patients.  
  Sharma K, Eltayeb B, McGowan T, Dunn S, Alzahabi B, Ziyadeh F, Lewis E, Am J Kid Dis
• Collaborative Study Group: Factors predictive of outcome in severe lupus nephritis.  
  Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, Am J Kid Dis
• Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease.  
  White KE, Bilous RW, JASN
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.  
  Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, NEJM
• Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.  
  Friedman AN, Hunsicker LG, Selhub J, Bostom AG, Diabetes Care
• Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy.  
  Breyer JA, Bain RP, Evans JK, Nahman NS, Lewis EJ, Cooper M, McGill J, Berl T, Kidney Int
• Costo-efficacia di irbesartan in pazienti con diabete di tipo 2, ipertensione e nefropatia: prospettiva italiana.  
  Palmer AJ, Annemans L, Roze S, Lamotte M, Berto Ravera M, Rodby RA, Pharmacoeconomics-Italian
• Economic value of irbesartan in hypertension in patients with diabetes in the United States and Europe. The value of irbesartan: From clinical efficacy to cost effecti...  
  Rodby RA, Bengt Jönsson, HEE.IRB
• The case for increased renal replacement therapy dosing in ICU patients with acute renal failure: Re-examining Current Evidence.  
  Rodby RA, NxStage Medical, Inc
• Nephrogenic systemic fibrosis, gadolinium-based contrast exposure, and liver disease.  
  NxStage Medical, Inc, Am J Med
• A new equation to estimate glomerular filtration rate.  
  Levey, AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J, Ann Intern Med
• Estimating glomerular filtration rate from serum creatinine and cystatin C.  
  Inker lA, Schmidt CH, Tighiouart H, et al, N Engl J Med
• Accuracy of a glomerular filtration rate estimating equation over time in people with a wide range of kidney function.  
  Padala S, Tighiouart H, Inker L, Contreras G, Beck GJ, Lewis J, Steffes M, Rodby RA, Schmid CH, Levey AS, Amer J Kid Dis
• Disease specific patient reported outcome tools for systemic lupus erythematosus.  
  Jolly M, Pickard AS, Block J, Kumar R, Mikolaitis C, Wilke F, Rodby R, Fogg L, Sequeira W, Utset T, Cash T, Moldovan I, Katsaros E, Nicassio P, Ishimori M, Kosinsky M,..., Semin Arth Rheum
• Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria.  
  Korbet SM, Lewis EJ, Nephrol Dial Transplant
• Insulin therapy pathologically alters cholesterol ester transfer (CET) in insulin dependent diabetes mellitus (IDDM).  
  Bagdade J, Ritter M, Rodby R, Thistlewaite R, Fellner S, Dunn F, 64th Scientific Session of the American Heart Association
• A controlled trial of angiotensin-converting enzyme inhibition in type 1 diabetic nephropathy: Study design and patient characteristics.  
  Bain R, Rohde R, Hunsicker LG, McGill J, Kobrin S, Lewis EJ, J Am Soc Nephrol
• Management of the systemic lupus erythematosus patient with end-stage renal disease.  
  Rodby RA, Semin Dial
• Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis.  
  Schwartz MM, Lan S, Bonsib SM, Gephardt GN, Sharma HM, Am J Kid Dis
• Join now to see all

Books/Book Chapters

• Principles and Practice of Dialysis. 
  Chapter: Causes, diagnosis, and treatment of peritoneal membrane failure 
  Page 130 - 147Rodby RA, Korbet SMEditors: Henrich WL.Williams & Wilkens, Baltimore
• Quick Reference to Internal Medicine. 
  Chapter: Chapter 85: Acute Renal Failure 
  Page 1105 - 1114Rodby RAEditors: Bone R.Igaku-Shoin, New York
• Diagnostic Strategies for Internal Medicine, A Case Based Approach. 
  Chapter: Hyponatremia 
  Page 521 - 531Rodby RAEditors: Grodzin CJ, Schwartz S, and Bone RC.St. Louis, Mosby
• Diagnostic Strategies for Internal Medicine, A Case Based Approach. 
  Chapter: Polyuria 
  Page 531 - 538Rodby RA, Wester CWEditors: Grodzin CJ, Schwartz S, and Bone RC.St. Louis, Mosby
• Diagnostic Strategies for Internal Medicine, A Case Based Approach. 
  Chapter: Metabolic Acidosis 
  Page 538 - 557Rodby RAEditors: Grodzin CJ, Schwartz S, and Bone RC.St. Louis, Mosby
• Diagnostic Strategies for Internal Medicine, A Case Based Approach. 
  Chapter: Acute Renal Failure 
  Page 557 - 568Rodby RA, Wester CWEditors: Grodzin CJ, Schwartz S, and Bone RC.St. Louis, Mosby
• Diagnostic Strategies for Internal Medicine, A Case Based Approach. 
  Chapter: The Nephrotic Syndrome 
  Page 568 - 576Wester CW, Rodby RAEditors: Grodzin CJ, Schwartz S, and Bone RC.St. Louis, Mosby
• Ace Inhibition and Renoprotection. 
  Chapter: Effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: Study design and patient characteristics 
  Page 53 - 62Rodby RA, Rohde R, Mulcahy WS, Lewis EJEditors: Cooper ME, Remuzzi G.Euromed Communications Ltd, Haslemere UK
• Principles and Practice of Dialysis. 
  Chapter: Chapter 13: Causes, diagnosis, and treatment of peritoneal membrane failure 
  Page 185 - 209Korbet SM, Rodby RAEditors: Henrich WL.Williams & Wilkens, BaltimoreEdition 2nd,
• the International Handbook on Renal Disease. 
  Chapter: Chapter 4: Type II Diabetic Nephropathy 
  Page 41 - 51Rodby RA, Lewis EJEditors: Brenner BM, Kurokawa K.Euromed Communications Ltd, Haslemere UK
• Principles and Practice of Dialysis. 
  Chapter: Chapter 15: Causes, diagnosis, and treatment of peritoneal membrane failure 
  Page 206 - 226Korbet SM, Rodby RAEditors: Henrich WL.Lippincott Williams & Wilkens, BaltimoreEdition 3rd,
• Join now to see all

Abstracts/Posters

• Effects of celecoxib on urinary protein excretion in diabetic nephropathy.
  Sinsakul M, Sika M, Rodby R, Middleton J, Shyr Y, Clyne S, Lehrich R, Harris R, Lewis J, JASN, the 39th Annual Meeting of the American Society of Nephrology
• Laparoscopy in the early diagnosis and management of sclerosing encapsulating peritonitis.
  Kropp J, Sinsakul M, Butsch J, Rodby R, JASN, the 40th Annual Meeting of the American Society of Nephrology
• The LupusPRO©: A disease-specific patient reported outcome measure for systemic lupus erythematosus in the U.S.A.
  Jolly M, Pickard AS, Mikolaitis RA, Wilke CF, Rodby R, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori M, Wallace D, Weisman MH, Bl..., the annual meeting of the American College of Rheumatology, Philadelphia, PA
• Development and validation of a US specific patient reported outcome measure.
  Jolly M, Pickard AS, Wilke C, Lin H-W, Khandelwal S, Rodby R, Block J, the 71st annual meeting of the American College of Rheumatology, Boston MA
• Disease activity, body image and health status in lupus.
  Jolly M, Pickard AS, Mikolaitis R, Wilke C, Khandelwal S, Rodby R, Block J, the 71st annual meeting of the American College of Rheumatology, Boston, MA
• Satisfaction with care and health status in lupus.
  Jolly M, Pickard AS, Wilke C, Khandelwal S, Rodby R, Fogg L, Block J, the 71st annual meeting of the American College of Rheumatology, Boston, MA
• Effect of lupus on sexual health of women.
  Jolly M, Pickard AS, WIlke C, Khandelwal S, Rodby R, Block J, the 71st annual meeting of the American College of Rheumatology, Boston, MA
• Modification and preliminary validation of the lupus quality of life (LUPUSQOL) Index: US version.
  Jolly M, Pickard AS, The LS, Wilke C, Rodby R, Block J, the 14th Annual Meeting of the International Society for Quality of Life Research, Toronto, Canada
• Understanding limitations of patient reported clinical outcomes in lupus.
  Wilke CT, Jolly M, Khandelwal S, Rodby RA, Block JA, Pickard AS, ISPOR, Arlington, VA
• Ability of SF-35 and EQ- 5D to discriminate among disease activity levels in lupus.
  Wilke CT, Jolly M, Block JA, Rodby RA, Pickard AS, ISPOR, Arlington, VA
• Equations to estimate creatinine excretion rate: The CKD epidemiology collaboration.
  Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang Y, Greene T, Levey AS, the 43rd Annual Meeting of the American Society of Nephrology, Denver CO
• Effect of source population on the relationship of GFR estimates with “true GFR”.
  Greene T, Coresh J, Liang L, Becj G, Hamm L, Lewis J, Rodby R, Stevens L, Weir M, Schmid C, Levey A, JASN, the 39th Annual Meeting of the American Society of Nephrology
• Accelerated veno-venous hemofiltration (AVVH); an alternative modality for critically-ill patients requiring renal replacement therapy (RRT).
  Gashti C, Salcedo S, Rodby R, JASN, the 39th Annual Meeting of the American Society of Nephrology
• Comparison of GFR equations using serum cystatin and creatinine: A pooled analysis of 1706 individuals.
  Coresh J, Stevens L, Greene T, Eggers P, Kusek J, Van Lente F, Zhang L, Schmidt C, Stark P, Rohde R, Rodby R, Levey A, JASN, the 38th Annual Meeting of the American Society of Nephrology
• Cost-effectiveness of irbesartan 300 mg given early or late in patients with type 2 diabetes, hypertension and renal disease.
  Coyle D, Levin A, Muirhead N, Palmer A, Réne de Cotret P,Soroka S,Amin M, Chen R, Dupont D, Forte L, Rodby R, the 2005 Annual Conference of the Canadian Association for Population Therapeutics, Vancouver, Canada
• The potential US public health impact of irbesartan on the cost of ESRD in patients with type II diabetes, overt nephropathy and hypertension.
  Rodby R, Smitten A, Simon T, Chen R, JASN
• Irbesartan is projected to be cost and life saving in the USA for treatment of patients with type II diabetes, hypertension and microalbuminuria.
  Palmer A, Annemans L, Roze S, Lamotte M, Lapuerta P, Gabriel S, Chen R, Carita P, Villadary I, Villadary I, Rodby R, de Zeeuw D, Parving H, JASN, the 36th Annual Meeting of the American Society of Nephrology
• Blood flow rate effects in high-dose pre- dilution CVVH.
  Zhang W, Huang Z, Ahuja A, Rodby R, Clark W, Gao D, JASN, the 36th Annual Meeting of American Society of Nephrology
• Effect of pre-dilution replacement fluid administration on solute clearances in high-volume hemofiltration (HF).
  Ahuja A, Rodby R, Huang A, Gao D, Zhang W, Clark W, JASN, the 36th Annual Meeting of the American Society of Nephrology
• The increasing prevalence of microalbuminuria in the United States: Data from the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and NHANES ...
  Smitten A, Rodby R, Chen R, JASN, the 36th Annual Meeting of the American Society of Nephrology
• Radioactive I131 usage in end-stage renal disease: Nightmare or nuisance?
  Sinsakul M, Ali A, Roger A. Rodby, Semin Dial
• Infectious spondylodiscitis in hemodialysis.
  Roger A. Rodby, García-García P, Rivero A, del Castillo N, Jarque A, Getino MA, García-Pérez J, Navarro-González JF, Semin Dial
• Bullous skin lesions in a patient undergoing chronic hemodialysis.
  Roger A. Rodby, Ryali ME, Whittier WL, Semin Dial
• Management of refractory ascites using nocturnal home hemodialysis.
  Roger A. Rodby, Pauly RP, Sood MM, Chan CT, Semin Dial
• Cinacalcet induced hungry bone syndrome.
  Roger A. Rodby, Lazar ES, Stankus N, Semin Dial
• Join now to see all

Lectures

• What therapy to deliver when CVVH is not practical: Accelerated hemofiltration in the ICU. 
  NxStage Conference, ASN, Philadelphia, PA
• Advanced Glycosylation End-Products and the Complications of Diabetes. Symposium on Cardiovascular Disease in Diabetes. 
  San Diego, CA
• The Pharmacoeconomics of Captopril in Diabetic Nephropathy. 
  Conference on Diabetes and its Complications. Zeist, Netherlands
• Effects of BP-level During ACE-inhibition on Renal Function in IDDM Patients. 
  Third International Symposium on Proteinuria and Progressive Renal Disease. Amsterdam, Netherlands
• Systemic Lupus Erythematosus and End-Stage Renal Disease. 
  Short Course: Lupus Nephritis. The 29th Annual Meeting of the American Society of Nephrology
• American College of Physicians MKSAP 10 Review Course: Nephrology. 
  Chicago, IL
• Slowing Down the Progression of Renal Insufficiency: Role of Diet and Pharmacology. 
  Dompé Biotec in Nefrologia. Chicago, IL
• Renoprotection: Can ESRD be avoided? 
  Rush University Medical Center. Chicago, IL
• AVVH: A New Model for Continuous Renal Replacement Therapy. 
  NxStage Conference, ASN, San Diego, CA
• Pharmacoeconomic Challenges in the Management of Hypertension. 
  Symposium for 16th annual meeting of the Academy of Managed Care Pharmacy, San Francisco, CA
• Diabetic Nephropathy: Preventing Diabetes and its Complications. 
  The Fourth Annual Becton Dickinson JDF Conference. Franklin Lakes, NJ
• Acute Renal Failure: “The more things change the more they stay the same”. 
  Medical Grand Rounds. Rush University Medical Center. Chicago, IL
• Gadolinium Toxicity in renal disease: “Chicken Little” or “A Wolf in Sheep’s Clothing”? 
  Medical Grand Rounds. Rush University Medical Center. Chicago, IL
• Gadolinium vs Iodinated Contrast: Comparison of Nephrotoxicity. 
  Newer Iatrogenic Renal Disorders. The American Society of Nephrology Renal Week, San Francisco, CA
• Risk-benefit of Gadolinium vs Iodinated Contrast in CKD. 
  Clinical Meetings of the National Kidney Foundation, Dallas, TX
• CRRT in the ICU: Keeping Your Options Open. 
  Presbyterian Healthcare Hospital, Charlotte, NC
• AVVH, an alternative to CRRT in the ICU. 
  East Carolina University Medical Center, Raleigh, NC
• The Success and Failure of Hemodialysis: Time to go “Back to the Future”. 
  Medical Grand Rounds. Rush University Medical Center. Chicago, IL
• Nephrogenic Systemic Fibrosis: 3 Years Later. 
  Medical Grand Rounds. Rush University Medical Center. Chicago, IL
• Nephrogenic Systemic Fibrosis: Contrasting Opinions on the Risk of Gadolinium. 
  Medical Grand Rounds. Stroger Hospital of Cook County. Chicago, IL
• Diabetic Nephropathy: Role of ACE Inhibition. 
  Medical Grand Rounds Grant Hospital, Chicago, IL
• The Clinical Use of Erythropoietin. 
  St. Mary of Nazareth Hospital, Chicago, IL
• Present State of the Multicenter Trial of ACE Inhibition in Diabetic Nephropathy, Non-enzymatic Protein Glycosylation and Diabetic Complications. 
  Regional Meeting on Diabetic Nephropathy, Grenoble, France
• Diabetic Nephropathy-Current Issues & Therapy. 
  Thirty-Third Professional Symposium of the American Diabetes Association, Chicago, IL
• Diabetic Nephropathy. 
  Christ Hospital, Oak Lawn, IL
• Join now to see all